{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T09:35:34Z","timestamp":1768642534711,"version":"3.49.0"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Primary Sj\u00f6gren\u2019s syndrome (pSS) is a systemic autoimmune disease, characterized by mononuclear cell infiltrates in the salivary and lacrimal glands, leading to glandular atrophy and dryness. Patient heterogeneity and lack of knowledge regarding its pathogenesis makes pSS a difficult disease to manage.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>An exploratory analysis using mass cytometry was conducted of MAPK\/ERK and JAK\/STAT signaling pathways in peripheral blood mononuclear cells (PBMC) from 16 female medication free pSS patients (8 anti-Sj\u00f6gren\u2019s syndrome-related antigen A negative\/SSA- and 8 SSA+) and 8 female age-matched healthy donors after stimulation with interferons (IFNs).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We found significant differences in the frequencies of memory B cells, CD8+ T central and effector memory cells and terminally differentiated CD4+ T cells among the healthy donors and patient subgroups. In addition, we observed an upregulation of HLA-DR and CD38 in many cell subsets in the patients. Upon IFN\u03b12b stimulation, slightly increased signaling through pSTAT1 Y701 was observed in most cell types in pSS patients compared to controls, while phosphorylation of STAT3 Y705 and STAT5 Y694 were slightly reduced. IFN\u03b3 stimulation resulted in significantly increased pSTAT1 Y701 induction in conventional dendritic cells (cDCs) and classical and non-classical monocytes in the patients. Most of the observed differences were more prominent in the SSA+ subgroup, indicating greater disease severity in them.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Augmented activation status of certain cell types along with potentiated pSTAT1 Y701 signaling and reduced pSTAT3 Y705 and pSTAT5 Y694 induction may predispose pSS patients, especially the SSA+ subgroup, to upregulated expression of IFN-induced genes and production of autoantibodies. These patients may benefit from therapies targeting these pathways.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.854183","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T06:39:51Z","timestamp":1661150391000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Aberrant signaling of immune cells in Sj\u00f6gren\u2019s syndrome patient subgroups upon interferon stimulation"],"prefix":"10.3389","volume":"13","author":[{"given":"Irene","family":"Sarkar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders K.","family":"Aarebrot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silje M.","family":"Solberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Petrovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anagha M.","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brith","family":"Bergum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan G.","family":"Brun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Hammenfors","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Jonsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silke","family":"Appel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2011.06.007","article-title":"The complexity of sjogren's syndrome: novel aspects on pathogenesis","volume":"141","author":"Jonsson","year":"2011","journal-title":"Immunol Lett"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205375","article-title":"Epidemiology of primary sjogren's syndrome: a systematic review and meta-analysis","volume":"74","author":"Qin","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3109\/03009742.2010.536164","article-title":"The point prevalence of clinically relevant primary sjogren's syndrome in two Norwegian counties","volume":"40","author":"Goransson","year":"2011","journal-title":"Scand J Rheumatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13192","article-title":"Sjogren syndrome-associated lymphomas: an update on pathogenesis and management","volume":"168","author":"Nocturne","year":"2015","journal-title":"Br J Haematol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.122037","article-title":"Sj\u00f6gren syndrome","volume":"186","author":"Mavragani","year":"2014","journal-title":"CMAJ Can Med Assoc J = J l'Association Medicale Can"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.278448","article-title":"Autoantibodies present before symptom onset in primary sj\u00f6gren syndrome","volume":"310","author":"Jonsson","year":"2013","journal-title":"JAMA Network"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e328363eaa5","article-title":"New advances in the classification, pathogenesis and treatment of sjogren's syndrome","volume":"25","author":"Mavragani","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/art.39204","article-title":"Molecular subsetting of interferon pathways in sj\u00f6gren's syndrome","volume":"67","author":"Hall","year":"2015","journal-title":"Arthritis Rheumatol (Hoboken N.J.)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/j.jaci.2016.01.024","article-title":"Cytometry by time-of-flight immunophenotyping identifies a blood sjogren's signature correlating with disease activity and glandular inflammation","volume":"137","author":"Mingueneau","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.19842.1","article-title":"Recent advances in the search for a targeted immunomodulatory therapy for primary sjogren's syndrome","volume":"8","author":"Leverenz","year":"2019","journal-title":"F1000Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/sji.12622","article-title":"Patients with primary sjogren's syndrome have alterations in absolute quantities of specific peripheral leucocyte populations","volume":"86","author":"Davies","year":"2017","journal-title":"Scand J Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/854706","article-title":"Distribution of peripheral lymphocyte populations in primary sj\u00f6gren's syndrome patients","volume":"2015","author":"Sudzius","year":"2015","journal-title":"J Immunol Res"},{"key":"B13","article-title":"CD4+ t-lymphocytopenia\u2013a frequent finding in anti-SSA antibody seropositive patients with primary sj\u00f6gren's syndrome","volume":"31","author":"Mandl","year":"2004","journal-title":"J Rheumatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2011.150326","article-title":"Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway","volume":"70","author":"Higgs","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.10.006","article-title":"Type I interferons in sjogren's syndrome","volume":"12","author":"Yao","year":"2013","journal-title":"Autoimmun Rev"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00290","article-title":"Interferons in sjogren's syndrome: Genes, mechanisms, and effects","volume":"4","author":"Li","year":"2013","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201381","article-title":"Prevalence of interferon type I signature in CD14 monocytes of patients with sjogren's syndrome and association with disease activity and BAFF gene expression","volume":"72","author":"Brkic","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e32836200d2","article-title":"Autoimmunity and infection in sj\u00f6gren's syndrome","volume":"25","author":"Igoe","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jaut.2015.07.002","article-title":"And II interferon signatures in sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and sjogren's related lymphomagenesis","volume":"63","author":"Nezos","year":"2015","journal-title":"J Autoimmun"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1209724109","article-title":"Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases","volume":"109","author":"Hall","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex490","article-title":"Systemic interferon type I and type II signatures in primary sjogren's syndrome reveal differences in biological disease activity","volume":"57","author":"Bodewes","year":"2018","journal-title":"Rheumatol (Oxf)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1080\/03009740701606010","article-title":"Constitutive STAT3 activation in peripheral CD3(+) cells from patients with primary sj\u00f6gren's syndrome","volume":"37","author":"Ramos","year":"2008","journal-title":"Scand J Rheumatol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/cei.12614","article-title":"STAT-5 is activated constitutively in T cells, b cells and monocytes from patients with primary sj\u00f6gren's syndrome","volume":"181","author":"Pertovaara","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2016.03.010","article-title":"Cytokine-induced STAT1 activation is increased in patients with primary sj\u00f6gren's syndrome","volume":"165","author":"Pertovaara","year":"2016","journal-title":"Clin Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201747213","article-title":"Aberrant cell signalling in PBMCs upon IFN-alpha stimulation in primary sjogren's syndrome patients associates with type I interferon signature","volume":"48","author":"Davies","year":"2018","journal-title":"Eur J Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/gene.2008.94","article-title":"Additive effects of the major risk alleles of IRF5 and STAT4 in primary sj\u00f6gren's syndrome","volume":"10","author":"Nordmark","year":"2009","journal-title":"Genes Immun"},{"key":"B27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-1-4939-9650-6_2","article-title":"Immunophenotyping by mass cytometry","volume":"2032","author":"Behbehani","year":"2019","journal-title":"Methods Mol Biol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2012.02.010","article-title":"A deep profiler's guide to cytometry","volume":"33","author":"Bendall","year":"2012","journal-title":"Trends Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M511797200","article-title":"Role of STAT3 in type I interferon responses. negative regulation of STAT1-dependent inflammatory gene activation","volume":"281","author":"Ho","year":"2006","journal-title":"J Biol Chem"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.09.002","article-title":"Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases","volume":"31","author":"Hu","year":"2009","journal-title":"Immunity"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.2.609","article-title":"Cutting edge: role of STAT1, STAT3, and STAT5 in IFN-alpha beta responses in T lymphocytes","volume":"174","author":"Tanabe","year":"2005","journal-title":"J Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-60761-362-6_11","article-title":"Intracellular staining for analysis of the expression and phosphorylation of signal transducers and activators of transcription (STATs) in NK cells","volume":"612","author":"Miyagi","year":"2010","journal-title":"Methods Mol Biol (Clifton N.J.)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01978-14","article-title":"CD8 T cells in innate immune responses: Using STAT4-dependent but antigen-independent pathways to gamma interferon during viral infection","volume":"5","author":"Suarez-Ramirez","year":"2014","journal-title":"mBio"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20070401","article-title":"High basal STAT4 balanced by STAT1 induction to control type 1 interferon effects in natural killer cells","volume":"204","author":"Miyagi","year":"2007","journal-title":"J Exp Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.7.3571","article-title":"Distinct requirements for IFNs and STAT1 in NK cell function","volume":"165","author":"Lee","year":"2000","journal-title":"J Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/nri2958","article-title":"Genomic views of STAT function in CD4+ T helper cell differentiation","volume":"11","author":"O'Shea","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-05-428672","article-title":"Regulating type 1 IFN effects in CD8 T cells during viral infections: changing STAT4 and STAT1 expression for function","volume":"120","author":"Gil","year":"2012","journal-title":"Blood"},{"key":"B38","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/ar1905","article-title":"The p38 mitogen-activated protein kinase signaling cascade in CD4 T cells","volume":"8","author":"Dodeller","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00281","article-title":"Single cell based phosphorylation profiling identifies alterations in toll-like receptor 7 and 9 signaling in patients with primary sj\u00f6gren's syndrome","volume":"10","author":"Davies","year":"2019","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/nri1865","article-title":"The many paths to p38 mitogen-activated protein kinase activation in the immune system","volume":"6","author":"Ashwell","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12979-017-0096-1","article-title":"pERK-dependent defective TCR-mediated activation of CD4(+) T cells in end-stage renal disease patients","volume":"14","author":"Huang","year":"2017","journal-title":"Immun Ageing"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18091990","article-title":"The role of ERK signaling in experimental autoimmune encephalomyelitis","volume":"18","author":"Birkner","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B43","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3109\/08916930903374832","article-title":"Key role of ERK pathway signaling in lupus","volume":"43","author":"Gorelik","year":"2010","journal-title":"Autoimmunity"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201948129","article-title":"Cytometry by time of flight identifies distinct signatures in patients with systemic sclerosis, systemic lupus erythematosus and sjogrens syndrome","volume":"50","author":"van der Kroef","year":"2020","journal-title":"Eur J Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.118158","article-title":"Levels of plasmacytoid dendritic cells and type-2 myeloid dendritic cells are reduced in peripheral blood of patients with primary sjogren's syndrome","volume":"69","author":"Vogelsang","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120383","article-title":"Expression of toll-like receptor -7 and -9 in b cell subsets from patients with primary sjogren's syndrome","volume":"10","author":"Karlsen","year":"2015","journal-title":"PloS One"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-04992-x","article-title":"Association between comorbidities and extraglandular manifestations in primary sj\u00f6gren\u2019s syndrome: a multicenter cross-sectional study","volume":"39","author":"Zhang","year":"2020","journal-title":"Clin Rheumatol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/S0049-0172(00)80016-5","article-title":"Clinical evolution, and morbidity and mortality of primary sj\u00f6gren's syndrome","volume":"29","author":"Skopouli","year":"2000","journal-title":"Semin Arthritis Rheum"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez004","article-title":"T Cells in primary sj\u00f6gren\u2019s syndrome: targets for early intervention","volume":"60","author":"Verstappen","year":"2019","journal-title":"Rheumatology"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3390\/cells9010228","article-title":"Roles of CD38 in the immune response to infection","volume":"9","author":"Glar\u00eda","year":"2020","journal-title":"Cells"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02096","article-title":"Plasmacytoid DCs from patients with sjogren's syndrome are transcriptionally primed for enhanced pro-inflammatory cytokine production","volume":"10","author":"Hillen","year":"2019","journal-title":"Front Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.20623","article-title":"MIFlowCyt: the minimum information about a flow cutometry experiment","volume":"73","author":"Lee","year":"2008","journal-title":"Cytometry A"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for sjogren's syndrome: a revised version of the European criteria proposed by the American-European consensus group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"B54","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jim.2016.06.007","article-title":"An optimized multiplex flow cytometry protocol for the analysis of intracellular signaling in peripheral blood mononuclear cells","volume":"436","author":"Davies","year":"2016","journal-title":"J Immunol Methods"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.22625","article-title":"FlowSOM: Using self-organizing maps for visualization and interpretation of cytometry data","volume":"87","author":"Van Gassen","year":"2015","journal-title":"Cytometry A"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01315","article-title":"Development of a comprehensive antibody staining database using a standardized analytics pipeline","volume":"10","author":"Amir","year":"2019","journal-title":"Front Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nri3158","article-title":"Standardizing immunophenotyping for the human immunology project","volume":"12","author":"Maecker","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"20686","DOI":"10.1038\/srep20686","article-title":"Standardizing flow cytometry immunophenotyping analysis from the human ImmunoPhenotyping consortium","volume":"6","author":"Finak","year":"2016","journal-title":"Sci Rep"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B61","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s42003-019-0415-5","article-title":"Diffcyt: Differential discovery in high-dimensional cytometry via high-resolution clustering","volume":"2","author":"Weber","year":"2019","journal-title":"Commun Biol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.854183\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T06:39:54Z","timestamp":1661150394000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.854183\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,22]]},"references-count":61,"alternative-id":["10.3389\/fimmu.2022.854183"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.854183","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,22]]},"article-number":"854183"}}